[Management standards and quality control index for the clinical application of transarterial chemoembolization in the treatment of liver cancer (2024 edition)].

Transarterial chemoembolization (TACE) is currently one of the commonly used treatment methods for liver malignancies. The key to ensuring its efficacy is high-quality TACE performance and management.Therefore, to further promote the quality control indicators line for TACE clinical application in the treatment of liver cancer, the National Center for Healthcare Quality Management in Comprehensive Interventional Radiology combined evidence-based medicine, expert consensus, and conditions in China to draft and formulate the "Management standards and quality control index for the clinical application of transarterial chemoembolization in the treatment of liver cancer (2024 edition)" so as to affirm the standardized, precise, and individualized application in clinical practice and improve the overall efficacy in patients with liver malignancies.